loading page

What about incorporating selenium in the therapeutic regimen of SARS-CoV-2?
  • Bachir Benarba,
  • Atanasio Pandiella
Bachir Benarba
Laboratory Research on Biological Systems and Geomatics
Author Profile
Atanasio Pandiella
Instituto de Biología Molecular y Celular del Cáncer, CSIC-IBSAL-Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
Author Profile

Abstract

We suggest that patients with COVID-19 may be at higher risk for selenium deficiency and, therefore, their selenium status should be assessed. Moreover, we suggest incorporating selenium supplementation to enhance their immune response and reduce the SARS-CoV-2 virulence.